Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0740441 (
acute diarrhea
)
2,275
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The microflora and pH of gastric contents were determined in breast-fed and in bottle-fed normal infants, in well nourished infants with
acute diarrhoea
and in infants with chronic
diarrhoea
and protein-calorie malnutrition. The last group of infants was reevaluated after recovery from
diarrhoea
and protein-calorie malnutrition. A bactericidal pH effect below 2-5 was observed. Bottle-fed controls had low pH values and low bacterial concentrations, whereas infants with chronic
diarrhoea
and protein-calorie malnutrition had high pH values and bacterial overgrowth, essentially of Gram-negative bacilli. After recovery, the only remaining alteration was the frequent isolation of yeast-like fungi in low concentrations. Infants with
acute diarrhoea
, except for the isolation more frequently of yeast-like fungi, presented no alterations; this seems to indicate that pH alterations and Gram-negative bacilli overgrowth occurred during the evolution of the disease to a chronic state. Breast-fed normal infants had hydrogen-ion concentrations similar to those of the chronic
diarrhoea
group, but without Gram-negative bacilli overgrowth, suggesting that other factors, besides pH, regulate bacterial growth in the gastric contents of these groups of infants.
...
PMID:Gastric pH and microflora of normal and diarrhoeic infants. 0 Feb 74
Much clinical experience has been gained in the use of the glucose/electrolyte oral solutions in the treatment of
acute diarrhea
. Those patients who are in shock or too weak to drink need intravenous fluids to correct their total deficit. With isotonic polyelectrolyte fluids rehydration may be achieved in 2-4 hours. Subsequently, most of these patients can be given oral fluids to replace continuing stool loss. Patients who are not in shock and who are sufficiently strong to drink at the outset nearly always can be rehydrated with oral fluids alone. Vomiting is most likely caused by acidosis and volume depletion, and these can be corrected in severely dehydrated patients by intravenous therapy and by oral therapy in those not in shock and able to drink by oral therapy. Proponents of oral glucose/electrolyte therapy for
diarrhea
, like other proponents of new treatments, have great visions of its benefits to the world, yet these visions require validation. The biggest problem will be getting glucose and electrolytes to where they are most needed -- at the level of home and village.
...
PMID:Editorial: Oral glucose/electrolyte therapy for acute diarrhoea. 4 28
61 Boston children aged five years or less with
acute diarrhoea
were studied for evidence of infection with Escherichia coli strains that produce heat-labile enterotoxin (L.T.) or with a reovirus-like agent associated with childhood gastroenteritis. This represented the first evaluation of the prevalence of disease produced by these two agents in the same population. E. coli, isolated from acute-phase stool specimens, were tested in adrenal-cell tissue-culture and adult-rabbit ileal-loop assays for L.T. Acute and convalescent phase sera, collected from 31 children, were tested by the adrenal-cell assay for anti-L.T. activity. None of the 61 children demonstrated evidence of infection with L.T.-positive E. coli. Paired sera from 31 of the children studied were also tested for evidence of recent infection with the reovirus-like agent by determining titres of immunofluorescent-staining antibody to the serologically related Nebraska calf
diarrhoea
virus. 11 of the children (35%) had evidence of recent infection. These results suggest that an important proportion of endemic
acute diarrhoea
of young children in Boston is caused by the reovirus-like agent, and that disease caused by L.T.-producing E. coli is uncommon.
...
PMID:Role of heat-labile toxigenic Escherichia coli and Reovirus-like agent in diarrhoea in Boston children. 5
20 consecutive child admissions to a Calcutta, India, hospital with
acute diarrhea
and moderate to severe clinical dehydration were studied. They were treated with an oral sucrose/electrolyte solution, which achieved complete hydration in 19 out of the 20 cases; 1 child did not respond and needed intravenous therapy. Vomiting, abdominal distension, and appearance of sugar in the stools during oral therapy did not interfer with its success. A child was considered to have recovered when the body weight had stabilized and when there was no further
diarrhea
, a process requiring 5-6 days. In addition, recovery involved restoration of plasma-bicarbonate to normal levels, falls in the hematocrit values and in the plasma specific gravidity, and complete clinical recovery. Solutions of glucose/electrolytes have already been used in the treatment of
acute diarrhea
. Replacement of glucose with sucrose is preferable since it is less expensive and more readily available in developing areas. This study showed that replacement of the glucose with sucrose is as effective.
...
PMID:Evaluation of a sucrose/electrolyte solution for oral rehydration in acute infantile diarrhoea. 6 56
Gastrointestinal physiology, and the pathophysiology, diagnosis, symptoms and treatment of acute and chronic
diarrhea
are reviewed. Drugs used in the treatment of
diarrhea
include opiates (morphine, codeine), synthetic anti-diarrheals (diphenoxylate, loperamide), anticholinergics (atropine, propantheline), adsorbents (kaolin, pectin, cholestyramine resin) and Lactobacillus acidophilus. Chronic
diarrhea
and
acute diarrhea
caused by microorgansims, drugs and viruses are described. The management of
diarrhea
can be divided into three categories: (1) supportive therapy (fluid and electrolyte replacement); (2) symptomatic therapy which improves the consistency of the stool and reduces the frequency of bowel movements; and (3) specific therapy aimed at treating the cause (e.g., antibiotics for bacteria-induced
diarrhea
) or blocking the cellular mechanisms of fluid and electrolyte loss. Most acute diarrheal conditions can be managed successfully by avoiding oral solids and ingesting carbohydrate-electrolyte solutions. Synthetic antidiarrheals may increase the toxicity associated with bacterial diahhrea.
...
PMID:Drug therapy reviews: pharmacotherapy of diarrhea. 11 47
Rotaviruses (duoviruses) can be found in more than half the cases of
acute diarrhoea
in children up to the age of six or seven. About that age almost everyone has antibodies to them. Second infections occur and may not be as rare as laboratory findings so far suggest. Very young infants sometimes get subclinical disease-the effect of maternal antibody transmitted across the placenta? Very similar viruses, all possessing a common antigen detectable by immunofluorescence, are known to infect and/or cause
diarrhoea
in children, calves, piglets, mice, foals and monkeys. The calf virus and the human virus both infect piglets; piglet virus infects calves; we don't know whether any of these can infect children. Other mammals probably have similar
diarrhoea
viruses. An antigen common to all these viruses is probably in the inner capsid layer, and "species-specific" antigens are probably in the outer capsid layer. A precise test for comparing different strains is bably needed. Adenoviruses possibly cause a smaller proportion of cases of
diarrhoea
. Coronaviruses, well-known as enteric pathogens of pigs and calves, appear also to infect adults and children. 27 nm particles and 22-23 nm particles of density 1.4 (and other particles) can be found in faeces of children with natural
diarrhoea
and adults with experimental
diarrhoea
, sometimes in enormous numbers. It is not yet established whether they cause disease. Rotaviruses, animal coronaviruses and "Norwalk" virus attack the disaccharidase-producing epithelium of the small bowel; adenovirus pathology is unknown.A safe attenuated live vaccine strain of the human rotavirus urgently needs to be developed.
...
PMID:Implications of recent virological researches. 18 37
The rate of poliovirus excretion was found to be 64.6% in a group of 108 normal children and 11.95% in 184 diarrheal children.
Diarrhea
was due to Shigella in 70% of cases. This drew our attention to the presence of an etiologic relationship between the two findings, which may have a direct effect on the low efficiency of oral poliovaccine in our Country. Effect of Shigella infection on the take of oral poliovaccine was investigated in 14 normal and 10 children having
acute diarrhea
due to Shigella. Vaccine virus excretion was detected in 64.2% of normal children and only in 10% of diarrheal children. In vitro studies were done to determine the effect of killed Shigella suspensions or their endotoxin on the replication of poliovirus in tissue culture. Reduction of virus titre from 1-3 logs in the presence of killed Shigella or its endotoxin was observed. The sites of action and interfering factor (s) are discussed.
...
PMID:The influence of bacillary dysentery on the efficiency of oral poliovaccine in Egypt. 19 25
Surveillance of 2,041 babies born during 4 winter months in one obstetric hospital in Melbourne, Australia, showed that 215 developed
acute diarrhea
during the first 2 weeks of life. Babies requiring special care from birth had a high incidence of sporadic
diarrhea
(36%). The incidence of
diarrhea
among healthy full-term babies was low if they were "rooming-in" with their mothers (2 to 3%) but high if they were housed in communal nurseries (29%). The most important factor influencing incidence of
diarrhea
was proximity to other newborn babies and frequency of handling by related adults. Breast feeding did not always protect babies from
diarrhea
. Excretion of rotaviruses was temporally retlated to
diarrhea
in 61 to 76% of healthy full-term babies and in 44% of babies requiring special care. Other eneteric pathogens, including enerotoxigenic Escherichia coli, were occasionally isolated. Calculation of the ratios of symptomatic to asymptomatic infection suggests that babies requiring special care are much more likely to develop symptomatic illness after rotavious infection than are full-term babies.
...
PMID:Diarrhea and rotavirus infection associated with differing regimens for postnatal care of newborn babies. 22 7
343 children with
acute diarrhea
were studied from january 1976 to september 1977. Rotavirus was the agent most frequently isolated (18 per cent) followed by Shigella (12 per cent) and Salmonella (10 per cent). Enterotoxigenic E. coli was identified in 8 per cent and invasive E. coli only in two cases. 80 per cent of isolated rotavirus fell in the neonate group and 25 per cent in the infant group.
Diarrhea
caused by rotavirus had a short duration, fever was negligible and abundant liquid stools were present without leukocytes in the fecal mucus and with a high percentage (48 per cent) of transient lactose intolerance. Polymorphonuclear leukocytes were found in fecal mucus in 75 per cent of cases caused by Shigella and only in 40 per cent of cases where the causal agent was Salmonella.
...
PMID:[Acute infectious gastroenteritis. Etiology and its correlation with clinical manifestations and fecal mucus]. 22 38
Loperamide, a butyramide derivative is a new agent for use in symptomatic control of acute non-specific
diarrhoea
and chronic
diarrhoea
. Unlike diphenoxylate or codeine, loperamide does not appear to exert opiate activity in man at normal therapeutic doses. In
acute diarrhoea
, loperamide provides more rapid control of symptoms than diphenoxylate when given in a flexible dosage according to unformed bowel movements, and in single dose studies 4mg loperamide has a much longer duration of effect than 5mg diphenoxylate. Loperamide is probably superior to diphenoxylate in providing symptomatic control of chronic
diarrhoea
such as that associated with chronic inflammatory bowel disease or following gastrointestinal surgery. It has been used for up to 3 years in such conditions without evidence of tolerance. The possibility of once daily dosage of loperamide in chronic
diarrhoea
is an advantage. Side-effects have not proved a problem.
...
PMID:Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea. 34 29
1
2
3
4
5
6
7
8
9
10
Next >>